Canada - English - Health Canada

teva canada limited - prazosin (prazosin hydrochloride) - tablet - 1mg - prazosin (prazosin hydrochloride) 1mg - alpha-adrenergic blocking agents

Canada - English - Health Canada

teva canada limited - prazosin (prazosin hydrochloride) - tablet - 2mg - prazosin (prazosin hydrochloride) 2mg - alpha-adrenergic blocking agents

Canada - English - Health Canada

teva canada limited - prazosin (prazosin hydrochloride) - tablet - 5mg - prazosin (prazosin hydrochloride) 5mg - alpha-adrenergic blocking agents

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prazosin hydrochloride, quantity: 5.5 mg (equivalent: prazosin, qty 5 mg) - tablet, uncoated - excipient ingredients: microcrystalline cellulose; lactose monohydrate; polysorbate 80; croscarmellose sodium; magnesium stearate - in patients with hypertension: prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. it can be used as the initial and sole agent or it may be employed in a general treatment programme in conjunction with other antihypertensive agents. renal blood flow and glomerular filtration rate are not impaired by long term oral administration. prazosin can be used with safety in hypertensive patients with impaired renal function. in patients with congestive heart failure: prazosin is indicated in the treatment of severe refractory congestive heart failure. prazosin may be added to the therapeutic regimen in those patients who have become refractory to conventional therapy with cardiac glycosides and diuretics. in patients with raynaud's phenomenon and raynaud's disease: prazosin is indicated in the treatment of raynaud's phenomenon and raynaud's disease. benign prostatic hyperplasia: prazosin is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia in patients awaiting prostatic surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prazosin hydrochloride, quantity: 2.2 mg (equivalent: prazosin, qty 2 mg) - tablet, uncoated - excipient ingredients: croscarmellose sodium; lactose monohydrate; polysorbate 80; magnesium stearate; microcrystalline cellulose - in patients with hypertension: prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. it can be used as the initial and sole agent or it may be employed in a general treatment programme in conjunction with other antihypertensive agents. renal blood flow and glomerular filtration rate are not impaired by long term oral administration. prazosin can be used with safety in hypertensive patients with impaired renal function. in patients with congestive heart failure: prazosin is indicated in the treatment of severe refractory congestive heart failure. prazosin may be added to the therapeutic regimen in those patients who have become refractory to conventional therapy with cardiac glycosides and diuretics. in patients with raynaud's phenomenon and raynaud's disease: prazosin is indicated in the treatment of raynaud's phenomenon and raynaud's disease. benign prostatic hyperplasia: prazosin is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia in patients awaiting prostatic surgery.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - prazosin hydrochloride, quantity: 1.1 mg (equivalent: prazosin, qty 1 mg) - tablet, uncoated - excipient ingredients: lactose monohydrate; microcrystalline cellulose; croscarmellose sodium; magnesium stearate; polysorbate 80 - in patients with hypertension: prazosin is indicated in the treatment of hypertension of varied aetiology and all grades of severity. it can be used as the initial and sole agent or it may be employed in a general treatment programme in conjunction with other antihypertensive agents. renal blood flow and glomerular filtration rate are not impaired by long term oral administration. prazosin can be used with safety in hypertensive patients with impaired renal function. in patients with congestive heart failure: prazosin is indicated in the treatment of severe refractory congestive heart failure. prazosin may be added to the therapeutic regimen in those patients who have become refractory to conventional therapy with cardiac glycosides and diuretics. in patients with raynaud's phenomenon and raynaud's disease: prazosin is indicated in the treatment of raynaud's phenomenon and raynaud's disease. benign prostatic hyperplasia: prazosin is indicated as an adjunct in the symptomatic treatment of urinary obstruction caused by benign prostatic hyperplasia in patients awaiting prostatic surgery.

United States - English - NLM (National Library of Medicine)

cardinal health - prazosin hydrochloride (unii: x0z7454b90) (prazosin - unii:xm03yj541d) - prazosin 1 mg - prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and

Canada - English - Health Canada

rhodiapharm inc - prazosin (prazosin hydrochloride) - tablet - 1mg - prazosin (prazosin hydrochloride) 1mg - alpha-adrenergic blocking agents

Canada - English - Health Canada

rhodiapharm inc - prazosin (prazosin hydrochloride) - tablet - 2mg - prazosin (prazosin hydrochloride) 2mg - alpha-adrenergic blocking agents

Canada - English - Health Canada

rhodiapharm inc - prazosin (prazosin hydrochloride) - tablet - 5mg - prazosin (prazosin hydrochloride) 5mg - alpha-adrenergic blocking agents